Penserra Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11K | Buy |
108
+3
| +3% | +$268 | ﹤0.01% | 903 |
|
|
2026
Q1 | $7K | Sell |
105
-3
| -3% | -$231 | ﹤0.01% | 895 |
|
|
2025
Q4 | $8K | Buy |
108
+3
| +3% | +$237 | ﹤0.01% | 862 |
|
|
2025
Q3 | $7K | Buy |
105
+3
| +3% | +$206 | ﹤0.01% | 857 |
|
|
2025
Q2 | $7K | Hold |
102
| – | – | ﹤0.01% | 843 |
|
|
2025
Q1 | $6K | Sell |
102
-3,187
| -97% | -$191K | ﹤0.01% | 912 |
|
|
2024
Q4 | $147K | Buy |
3,289
+3,187
| +3,125% | +$179K | ﹤0.01% | 792 |
|
|
2024
Q3 | $6K | Hold |
102
| – | – | ﹤0.01% | 923 |
|
|
2024
Q2 | $6K | Sell |
102
-3
| -3% | -$188 | ﹤0.01% | 1049 |
|
|
2024
Q1 | $8K | Sell |
105
-5,839
| -98% | -$446K | ﹤0.01% | 939 |
|
|
2023
Q4 | $469K | Sell |
5,944
-1,249
| -17% | -$88.9K | 0.01% | 545 |
|
|
2023
Q3 | $501K | Sell |
7,193
-1,109
| -13% | -$78.6K | 0.01% | 506 |
|
|
2023
Q2 | $573K | Buy |
8,302
+7,536
| +984% | +$536K | 0.01% | 481 |
|
|
2023
Q1 | $56K | Buy |
766
+694
| +964% | +$58.2K | ﹤0.01% | 844 |
|
|
2022
Q4 | $6K | Buy |
+72
| New | +$6.95K | ﹤0.01% | 1000 |
|
|
2022
Q2 | – | Sell |
-3,931
| Closed | -$397K | – | 1408 |
|
|
2022
Q1 | $397K | Buy |
3,931
+3,565
| +974% | +$375K | 0.01% | 552 |
|
|
2021
Q4 | $37K | Sell |
366
-6
| -2% | -$554 | ﹤0.01% | 1096 |
|
|
2021
Q3 | $31K | Buy |
372
+72
| +24% | +$6.03K | ﹤0.01% | 1174 |
|
|
2021
Q2 | $25K | Buy |
+300
| New | +$24.6K | ﹤0.01% | 1113 |
|
|
2020
Q4 | – | Sell |
-1,428
| Closed | -$83K | – | 1030 |
|
|
2020
Q3 | $83K | Buy |
1,428
+141
| +11% | +$8.77K | ﹤0.01% | 520 |
|
|
2020
Q2 | $83K | Sell |
1,287
-273
| -18% | -$17.2K | ﹤0.01% | 595 |
|
|
2020
Q1 | $98K | Buy |
1,560
+244
| +19% | +$16.3K | 0.01% | 580 |
|
|
2019
Q4 | $88K | Buy |
1,316
+128
| +11% | +$8.99K | 0.01% | 639 |
|
|
2019
Q3 | $74K | Buy |
1,188
+320
| +37% | +$19K | 0.01% | 608 |
|
|
2019
Q2 | $47K | Buy |
868
+172
| +25% | +$9.26K | ﹤0.01% | 597 |
|
|
2019
Q1 | $37K | Buy |
+696
| New | +$43K | ﹤0.01% | 584 |
|
|
2017
Q1 | – | Sell |
-199
| Closed | -$15K | – | 619 |
|
|
2016
Q4 | $15K | Buy |
199
+39
| +24% | +$3.16K | ﹤0.01% | 724 |
|
|
2016
Q3 | $14K | Buy |
160
+64
| +67% | +$6.04K | ﹤0.01% | 739 |
|
|
2016
Q2 | $9K | Buy |
96
+32
| +50% | +$3.19K | ﹤0.01% | 723 |
|
|
2016
Q1 | $6 | Sell |
64
-4
| -6% | -$389 | ﹤0.01% | 619 |
|
|
2015
Q4 | $7K | Buy |
+68
| New | +$6.66K | ﹤0.01% | 613 |
|
Other funds holding CVS
Penserra Capital Management's CVS Position: Q2 2026 in Review
Penserra Capital Management increased its CVS Health (CVS) stake by 2.9% in Q2 2026, buying an estimated $268 and bringing the position to 108 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #903.
Penserra Capital Management first reported a position in CVS in Q4 2015 and has held it in 31 quarters since. The position peaked at $573K in Q2 2023. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Penserra Capital Management held 108 shares of CVS Health worth $11K as of Q2 2026.
- Penserra Capital Management bought 3 CVS Health shares in Q2 2026, an estimated $268.
- CVS Health made up ﹤0.01% of Penserra Capital Management's portfolio in Q2 2026, its #903 holding.
- Penserra Capital Management first reported a position in CVS Health in Q4 2015 and has held it in 31 quarters since.
- Penserra Capital Management's CVS Health position peaked at $573K in Q2 2023.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.